This peptide terminology glossary explains, in plain English, the words you are most likely to meet in peptide science, research papers, and laboratory reports. It covers the chemistry basics (amino acids, residues, peptide bonds), biology (receptors, half-life), laboratory testing (HPLC, mass spectrometry, assay), and quality documents (specifications, certificates of analysis). Where a term has a formal definition in international guidance, we cite it.
Key Takeaways
- Many peptide terms have formal definitions in IUPAC–IUB nomenclature or ICH and EMA guidance [1][2][4].
- Identity, purity, and quantity (assay) are different concepts. Lab reports often confuse them [2][4].
- Peptide size categories (oligopeptide, polypeptide, protein) are conventions, and different authors and regulators draw the lines differently [1].
- Terms like "counter-ion," "water content," and "net peptide content" explain why a peptide powder is rarely 100% peptide by weight [4].
How to Use This Peptide Terminology Glossary
Terms are listed alphabetically. Words in italics within a definition have their own entry. For deeper explanations, follow the links to our full guides.
A
Acceptance criteria
The numerical limits, ranges, or other measures that a test result must meet for a material to pass [3]. Example: "Purity: not less than 98.0%."
Accuracy
How close a measured value is to the true or accepted reference value [2].
Acetate
The counter-ion most commonly used for synthetic peptides [4]. See counter-ion.
Aggregate
A larger, often disordered cluster of many peptide molecules that forms through uncontrolled self-association [4]. Aggregates are one type of high molecular weight impurity.
Agonist
A molecule that binds to a receptor and activates it. Most existing peptide drugs that target G protein-coupled receptors are agonists [10].
Amino acid
An organic compound containing both an amino group and a carboxyl (acid) group. The alpha-amino acids joined together in peptides and proteins each have a distinctive side chain [1][11].
Amino acid analysis (AAA)
A test that breaks a peptide into its individual amino acids and measures them. It is used to check composition and can contribute to identity and content testing [4].
Amino acid residue
What remains of an amino acid once it has been built into a peptide chain (water is lost when the bond forms). "A 10-residue peptide" means a chain of 10 amino acids [1].
Antagonist
A molecule that binds to a receptor without activating it, blocking the natural signal [10].
Assay (content)
A test measuring how much of the substance is present. For synthetic peptides, assay may use liquid chromatography against a reference standard, amino acid analysis, nitrogen analysis, or quantitative NMR [4]. Not the same as purity. See Identity vs. Purity vs. Quantity Testing.
B
Batch (lot)
A defined quantity of material produced in one manufacturing run and identified by a unique batch number. A certificate of analysis is usually prepared for each batch [8].
Biological activity
The specific ability of a product to achieve a defined biological effect. Potency is the quantitative measure of biological activity [3].
C
Certificate of analysis (COA or CoA)
A document listing the tests performed on a sample, the results, the acceptance criteria, and whether the sample complies with its specification [8]. See What Is a Certificate of Analysis (COA)?.
Chromatogram
The chart produced by chromatography (such as HPLC), showing detector signal over time. Each component appears as a peak.
Co-elution
When two or more substances leave a chromatography column at the same time and appear as a single peak. EMA guidance warns about the risk of co-eluting impurities in peptide testing [4].
Counter-ion
An oppositely charged ion paired with a charged peptide to form a salt. Acetate is usual. Trifluoroacetate (TFA) and chloride are also possible. The type and amount of counter-ion should be controlled because it can affect a peptide's properties [4].
C-terminus
The end of a peptide chain with a free (or modified) carboxyl group. By convention it is written on the right [1].
D
D-amino acid / L-amino acid
Mirror-image forms of chiral amino acids. Only L-amino acids are used in protein biosynthesis [1]. D-amino acids are sometimes introduced into synthetic peptides to resist enzyme breakdown [9].
Deamidation
A chemical degradation reaction, affecting certain amino acid side chains, that changes a peptide's structure. It is listed among typical degradation pathways in regulatory guidance [3][4].
Degradation product
A molecular variant that forms over time or through exposure to factors such as light, temperature, pH, or water. Examples include deamidation, oxidation, and aggregation products [3].
Deletion sequence
An impurity in which one or more amino acids are missing from the intended sequence, usually from incomplete reactions during synthesis [4].
Detection limit (DL)
The lowest amount of a substance that a method can detect, though not necessarily measure precisely [2].
Diastereomer / stereoisomer
A molecule with the same atoms and connections but a different 3D arrangement. In peptides, stereoisomers can form when an amino acid converts to its mirror-image form (epimerization) during synthesis [4].
E
Electrospray ionization (ESI)
A "soft" method of turning molecules into ions for mass spectrometry. The sample is sprayed as charged droplets. ESI typically produces peptide ions carrying several charges [6].
Endotoxin (bacterial endotoxin)
Contaminating molecules from certain bacteria. Bacterial endotoxin testing may be part of a peptide specification [4].
Epimerization
A chemical change that flips the 3D configuration at one stereocenter of an amino acid, creating a stereoisomer impurity [4].
Excipient
An ingredient intentionally added to a drug substance (for example, a buffer) that should not have pharmacological properties in the amount used [3].
H
Half-life (elimination half-life)
The time required for the concentration of a substance in the body to fall to half its initial value [7]. See Peptide Half-Life Explained.
High molecular weight (HMW) impurities
By-products heavier than the target peptide, such as dimers, oligomers, or aggregates, formed during synthesis or storage [4].
HPLC (high-performance liquid chromatography)
A technique that separates a liquid sample's components by pumping it through a packed column. It is the main method for measuring peptide purity [5]. See HPLC Testing Explained.
Hygroscopic
Readily absorbs moisture from the air. Peptides are often very hygroscopic powders, so water content is often tested [4].
I
Identity test
A test that confirms a material is the intended substance, based on unique aspects of its molecular structure [2][3]. EMA recommends at least two orthogonal methods for synthetic peptide identification [4].
Impurity
Any component in a material that is not the intended product (or an acceptable related substance or excipient) [3]. For peptides, impurities are often divided into peptide-related and non-peptide impurities [4].
Insertion sequence
An impurity in which an amino acid has been added more than once [4].
L
LC-MS
Liquid chromatography coupled to mass spectrometry. It separates components and then measures the mass of each [4].
Lyophilization
Freeze-drying: removing water from a frozen product under vacuum. Many peptides are supplied as lyophilized powders.
M
MALDI (matrix-assisted laser desorption/ionization)
A soft ionization method in which the sample is mixed with a matrix compound and hit by a laser. It generally produces singly charged ions and is often paired with a time-of-flight analyzer [6].
Mass spectrometry (MS)
A technique that measures the mass-to-charge ratio of ions. It is used to confirm a peptide's molecular mass and sequence [4][6]. See Mass Spectrometry for Peptides.
Mass-to-charge ratio (m/z)
What a mass spectrometer actually measures: an ion's mass divided by its charge [6].
MS/MS (tandem mass spectrometry)
Selecting an ion, breaking it into fragments, and measuring the fragments to obtain structural or sequence information [6].
N
Net peptide content
The proportion of a material's weight that is actually peptide, as opposed to water, counter-ions, and other components. It is determined with assay methods, and it is one reason regulatory guidance expects water and counter-ion content to be controlled [4].
N-terminus
The end of a peptide chain with a free (or modified) amino group. By convention it is written on the left [1].
O
Oligopeptide
A short peptide, generally fewer than about 10–20 residues [1].
Oligomer
An association of a few peptide molecules (often 2–10) that may be transient or undefined in structure [4].
Orthogonal methods
Analytical methods based on different scientific principles, used together so that one can detect what another might miss. Example: mass spectrometry plus HPLC retention time [4].
Oxidation
A chemical degradation reaction. In peptides, cysteine and methionine residues are particularly susceptible [4].
P
Peptide
Any compound produced by amide bond formation between the carboxyl group of one amino acid and the amino group of another [1].
Peptide bond
The amide bond linking amino acids in a peptide [1].
Peptide mapping
Cutting a peptide or protein into fragments with enzymes or chemicals and analyzing the fragments, often to confirm the sequence of longer peptides [4].
PEGylation
Attaching polyethylene glycol (PEG) chains to a molecule to increase its effective size, reduce kidney clearance, and shield it from enzymes. It is a half-life extension strategy [9].
Polypeptide
A longer chain of amino acids, beyond the oligopeptide range [1].
Potency
The quantitative measure of biological activity [3].
Precision
How closely repeated measurements of the same sample agree with each other (the degree of scatter) [2].
Primary structure
The sequence of amino acids in a peptide or protein [4].
Protein
A polypeptide of specific sequence, usually more than about 50 residues, though authors differ on the cut-off [1]. Some regulators use their own definitions. See Peptides vs. Proteins.
Purity
The proportion of the intended substance relative to impurities. For biotechnological products, ICH notes that absolute purity is difficult to determine and results are method-dependent [3]. Peptide purity is usually reported from HPLC as area percent [2].
Q
Quantitation limit (QL)
The lowest amount of a substance that a method can measure with suitable precision and accuracy [2].
Quaternary structure
The arrangement of two or more peptide chains assembled into a single functional complex [4].
R
Receptor
A protein, usually on the cell surface, that a signaling molecule binds to in order to trigger a response. Therapeutic peptides typically act by binding cell-surface receptors [9].
Reference standard (reference material)
A well-characterized, sufficiently homogeneous, and stable material used as a benchmark in testing [2].
Relative response factor
A correction used when an impurity produces a different detector signal than the reference material, for example because it absorbs UV light differently [2].
Relative retention time (RRT)
A peak's retention time compared with a reference peak. It can support identification [4].
Retention time (RT)
The time a component takes to pass through a chromatography column to the detector.
Retest date / expiry date
Dates on a COA or label that indicate how long a material's quality is supported under stated storage conditions [8].
Reversed-phase HPLC (RP-HPLC)
The most widely used HPLC mode for peptides. It uses a hydrophobic stationary phase (typically C8 or C18), and peptides elute in order of increasing hydrophobicity [5].
S
Secondary structure
Local arrangements of a peptide's backbone, such as helices, held together mainly by hydrogen bonds [4].
Sequence
The order of amino acids in a chain, written from the N-terminus to the C-terminus [1].
Solid-phase peptide synthesis (SPPS)
The main chemical method for making peptides. Amino acids are added one at a time to a chain anchored on a solid resin [9]. It was introduced by Merrifield in 1963 [9].
Specification
The list of tests, analytical procedures, and acceptance criteria that a material must meet.
Specificity / selectivity
The ability of a method to measure the intended substance without interference from other substances [2].
T
Tertiary structure
The overall three-dimensional folding of a peptide, driven by interactions between side chains [4].
TFA (trifluoroacetic acid / trifluoroacetate)
Widely used in HPLC mobile phases for peptides [5]. Trifluoroacetate can remain in purified synthetic peptides as a counter-ion, so residual TFA may be tested [4].
Time-of-flight (TOF)
A mass analyzer that separates ions by how long they take to travel down an evacuated tube [6].
Truncated sequence
A shortened peptide chain, for example one capped during synthesis so that it cannot keep growing [4].
W
Water content
The amount of water in a sample. It is tested because peptide powders can absorb moisture [4].
Frequently Asked Questions
What is the difference between a peptide and a polypeptide?
"Peptide" is the general term for amino acids linked by peptide bonds. "Polypeptide" usually refers to longer chains, while "oligopeptide" refers to short ones [1].
What does "residue" mean in peptide science?
A residue is one amino acid unit within a peptide chain, after water has been lost in forming the peptide bond [1].
What is the difference between purity and assay?
Purity describes how much of the detected material is the target compared with impurities. Assay (content) describes how much of the substance is actually present [2][4].
What does "orthogonal" mean on a lab report?
It means using independent methods based on different principles, such as mass spectrometry and HPLC, to cross-check a result [4].
What is a counter-ion in a peptide?
It is an oppositely charged ion, such as acetate or trifluoroacetate, that pairs with the peptide to form a salt and contributes to the powder's weight [4].
References
- IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and Symbolism for Amino Acids and Peptides (Recommendations 1983). Pure Appl Chem. 1984;56:595–624. https://doi.org/10.1351/pac198456050595 ↗ (web: https://iupac.qmul.ac.uk/AminoAcid/ ↗)
- ICH. Q2(R2): Validation of Analytical Procedures (2023), Glossary. https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf ↗
- ICH. Q6B: Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products, Glossary. https://database.ich.org/sites/default/files/Q6B%20Guideline.pdf ↗
- European Medicines Agency. Guideline on the Development and Manufacture of Synthetic Peptides (EMA/CHMP/CVMP/QWP/367182/2025). https://www.ema.europa.eu/en/development-manufacture-synthetic-peptides-scientific-guideline ↗
- Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 2007;386:3–55. https://doi.org/10.1007/978-1-59745-430-8_1 ↗
- Graham RLJ, Graham C, McMullan G. Microbial proteomics: a mass spectrometry primer for biologists. Microb Cell Fact. 2007;6:26. https://doi.org/10.1186/1475-2859-6-26 ↗
- Hallare J, Gerriets V. Elimination Half-Life of Drugs. In: StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK554498/ ↗
- World Health Organization. Model certificate of analysis. WHO Technical Report Series No. 1010, 2018, Annex 4. https://www.who.int/publications/m/item/trs1010-annex4 ↗
- Wang L, Wang N, Zhang W, et al. Therapeutic peptides: current applications and future directions. Signal Transduct Target Ther. 2022;7(1):48. https://doi.org/10.1038/s41392-022-00904-4 ↗
- Davenport AP, Scully CCG, de Graaf C, Brown AJH, Maguire JJ. Advances in therapeutic peptides targeting G protein-coupled receptors. Nat Rev Drug Discov. 2020;19(6):389–413. https://doi.org/10.1038/s41573-020-0062-z ↗
- Hou Y, Wu G. Nutritionally essential amino acids. Adv Nutr. 2018;9(6):849–851. https://doi.org/10.1093/advances/nmy054 ↗
Educational disclaimer: This glossary is for general educational purposes only. It is not medical, legal, or regulatory advice, and it does not recommend or evaluate any product. For health questions, consult a qualified healthcare professional. For regulatory questions, consult the relevant regulatory authority in your jurisdiction.